Japan Society of Clinical Trials and Research ( JPT Supplement )
Vol. 48 Suppl. 1 2020
■ REVIEW Clinical Trials and Research in Japan: Progress over the Past Decade
Introduction to the Special Feature： the Last Decade, COVID-19, the Next Decade
Y. Ohashi
Jpn Pharmacol Ther 2020; 48 (s1) : s5-6.
A Review of the Past Ten Years and Prospects for Clinical Data Management in Japan
H. Ohtsu
Jpn Pharmacol Ther 2020; 48 (s1) : s7-12.
Quality Control and Quality Assurance in Clinical Trials and Research
T. Yamaguchi
Jpn Pharmacol Ther 2020; 48 (s1) : s13-16.
Environmental Changes of Investigator-initiated Clinical Trials and the 10-year Progress in JCOG
K. Nakamura, et al
Jpn Pharmacol Ther 2020; 48 (s1) : s17-20.
The Last Decade of Challenge in WJOG
K. Takeda
Jpn Pharmacol Ther 2020; 48 (s1) : s21-24.
History of International Regulation―Focusing on GCP Renovation
O. Komiyama
Jpn Pharmacol Ther 2020; 48 (s1) : s25-29.
History of Creation and Development of Medical Innovation System in Academic Research Organizations in Japan
– Pharmaceutical Approval of Regenerative Medicine Products as a Part of Their Achievements
K. Kono, et al
Jpn Pharmacol Ther 2020; 48 (s1) : s30-38.
■ ORIGINAL ARTICLE
Development of RACI Charts for Involvement of Pharmaceutical Companies in Clinical Trials under the Clinical Trials Act
M. Mori, et al
Jpn Pharmacol Ther 2020; 48 (s1) : s39-56.
■ BRIEF REPORTS
Clarification of Problems in Supporting Clinical Research
R. Katashima, et al
Jpn Pharmacol Ther 2020; 48 (s1) : s57-64.
Development of the Core Competency Model for Program and Project Manager Defined by Clinical Trials Act in Japan
K. Iwasaki, et al
Jpn Pharmacol Ther 2020; 48 (s1) : s65-80.